Triple-Pathway Fat Loss. Maximum Metabolic Power.
🔬 Product Overview
Retatrutide is a next-generation triple hormone receptor agonist that targets GLP-1, GIP, and glucagon receptors simultaneously. This multi-receptor activation delivers a comprehensive metabolic effect, positioning Retatrutide as a leading compound in weight management and metabolic health research.
⸻
🚀 Key Benefits
• Triple Hormone Activation: Simultaneous stimulation of GLP-1, GIP, and glucagon receptors promotes synergistic effects on weight loss and metabolic regulation.
• Exceptional Weight Reduction: In a 48-week phase 2 clinical trial, participants achieved up to 24.2% body weight loss using a 12mg dose—outperforming leading agents like Ozempic and Mounjaro.
• Enhanced Metabolic Health: Research shows significant reductions in liver fat and improvements in key cardiometabolic markers, suggesting broad systemic benefits.
• Reduced Dosing Frequency: Thanks to its high potency, a single vial can last over 5 weeks, depending on the research protocol.
⸻
🧪 Composition
• Active Ingredient: Retatrutide
• Concentration: 10mg per vial
• Form: Lyophilized peptide powder
⸻
📦 Usage & Storage
• Intended Use: For research purposes only
• Storage: Store lyophilized powder in a cool, dry environment. After reconstitution, keep refrigerated at 2–8°C and use within the designated study period.
⸻
🧠Why Choose Retatrutide?
• Superior Efficacy: Delivers greater fat loss in less time compared to GLP-1 mono-agonists and dual agonists.
• Multi-Target Strategy: Addresses the complex hormonal pathways involved in appetite, fat storage, and energy regulation.
• Clinically Supported: Backed by rigorous clinical data demonstrating both safety and efficacy.
⸻
🔥 Pioneering the Future of Weight Loss Research
Retatrutide stands at the forefront of metabolic science. Its triple-action mechanism opens new possibilities for advanced studies targeting obesity, type 2 diabetes, and metabolic syndrome.
⸻
🛒 Now Available
Order your 10mg Retatrutide vial today for just £200.00
